Lakewood-Amedex Therapeutics names new chairman to board of directors
22 July 2020 -

It was reported on Tuesday that Lakewood-Amedex Therapeutics Inc, a US-based clinical-stage development company, has named Peter B. Corr, PhD as its new chairman of the board of directors of the company.

Dr Corr replaces Steve Parkinson, who will continue to serve as President and CEO.

With over 26 years of experience, Dr Corr has served in various companies such as Pfizer Inc, Auven Therapeutics Management LLLP, Imvax Inc, Hever Group and Critical Path Institute amongst others. He currently serves on the National Council for Washington University School of Medicine.